Agents and Actions

, Volume 1, Issue 4, pp 190–197 | Cite as

Psilocybin-induced contraction of nearby visual space

  • Roland Fischer
  • Richard Hill
  • Karen Thatcher
  • James Scheib
Research Reports


Using apparent fronto-parallel plane (AFP) monitoring techniques, the relative stability of the abathic plane, i.e. Euclidean visual space, was investigated in 16 volunteers with a median age of 23.5 years under 160 μg/kg psilocybininduced ergotropic arousal. Handwriting area and pressure were also measured in the same subjects.

Drug-induced contraction of nearby visual space was inferred from changes of AFP curvature and tilt, as well as from increased handwriting area at drug peak. The ‘rising horizon’ (Rennert) in the drawings of schizophrenics is also considered a manifestation of the contraction of visual space and is described in terms of an arousal-dependent transformation of constancies. The ‘projection’ of central nervous system activity as experience ‘out there’ is also discussed as an arousal-dependent learned constancy.


Nervous System Central Nervous System System Activity Relative Stability Monitoring Technique 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    K. Ogle,Researches in Binocular Vision, W. B. Saunders, Philadelphia 1950, p. 37.Google Scholar
  2. [2]
    U. Halldén,An Optical Explanation of Hering-Hillebrand's Horopter Deviation, A. M. A. Arch. of Opthalm.55, 830–835 (1956).Google Scholar
  3. [3]
    H. Isbell, A. Wolbach, A. Wilker andE. Miner,Cross-Tolerance between LSD and Psilocybin, Psychopharmacologia (Berlin)2, 147–159 (1961).CrossRefGoogle Scholar
  4. [4]
    A. Wolbach, H. Isbell andE. Miner,Cross-Tolerance between Mescaline and LSD-25, Psychopharmacologia (Berlin)3, 1–14 (1962).CrossRefGoogle Scholar
  5. [5]
    F. Hebbard andM. Fischer,Effect of Psilocybin, LSD and Mescaline on Small, Involuntary Eye Movements, Psychopharmacologia (Berlin)9, 146–156 (1966).CrossRefGoogle Scholar
  6. [6]
    R. Hill, R. Fischer andD. Warshay,Effects of Excitatory and Tranquilizing Drugs on Visual Perception: Spatial Distortion Thresholds, Experientia25, 171–172 (1969).CrossRefPubMedGoogle Scholar
  7. [7]
    R. Fischer, R. Hill andD. Warshay,Effects of the Psychodysleptic Drug Psilocybin on Visual Perception: Changes in Brightness Preference, Experientia25, 166–169 (1969).CrossRefPubMedGoogle Scholar
  8. [8]
    R. Fischer,Psychotomimetic Drug-Induced Changes in Space and Time Proc. 4th Intl. Congr. Pharmacol.3 21–61 (Benno Schwabe Basel 1970).Google Scholar
  9. [9]
    R. Fischer, T. Kappeler, P. Wisecup andK. Thatcher,Measurement of Handwriting Area to Pressure Ratios During Psylocibin-Induced Hallucinations Agents and Actions1, 42–52 (1969).PubMedGoogle Scholar
  10. [10]
    R. Fischer,Prediction and Measurement of Perceptual-Behavioral Change in Drug-Induced Hallucinations, in: W. Keup, ed., Proc. Ann. Meeting Eastern Psychiatric Res. Assoc., New York, in press (1970).Google Scholar
  11. [11]
    R. Fischer, P. Marks, R. Hill andM. Rocky,Personality Structure as the Main Determinant of Drug-Induced (Model) Psychoses, Nature (London)218, 296–298 (1968).Google Scholar
  12. [12]
    R. Fischer andD. Warshay,Psilocybin-Induced Autonomic, Perceptual and Behavioral Change, Pharmakopsychiatrie Neuro-Psychopharmakol. (Thieme, Stuttgart)1, 291–302 (1968).Google Scholar
  13. [13]
    H. v. Helmholtz, Physiological Optics3, Geo. Banta, Menasha, Wisconsin 1925, p. 318/19.Google Scholar
  14. [14]
    P. v. Lieberman,Beitrag zur Lehre von der binokularen Tiefenlokalisation, Ztschr. Psychol. Physiol. Sinnesorgane44, 428–443 (1910),p. 431.Google Scholar
  15. [15]
    G. Kienle,Die optischen Wahrnehmungsstörungen und die nichteuklidische Struktur des Sehraumes, Thieme, Stuttgart 1968, p. 42.Google Scholar
  16. [16]
    R. Hill,Comments on the Geometry of Psilocybin-Induced Changes in Visual Space, Proc. 4th Intl. Congr. Pharmacol.3, 61–71 (Benno Schwabe, Basel 1970).Google Scholar
  17. [17]
    M. Knoll, J. Kugler, O. Höfer andS. Lawder,Effects of Chemical Stimulation of Electrically-Induced Phosphenes on Their Bandwidth, Shape, Number and Intensity, Confin. Neurol.23, 201–226 (1963).PubMedGoogle Scholar
  18. [18]
    R. Fischer, F. Griffin andL. Liss,Biological Aspects of Time in Relation to (Model) Psychoses, Ann. N. Y. Acad. Sci.96, 44–65 (1962); also see p. 92.PubMedGoogle Scholar
  19. [19]
    R. Fischer,Psilocybin Reactivity and Time Contraction as Measured by Psychomotor Performance, Arzneimittel-Forschung (Drug Res.)16, 180–185 (1966).Google Scholar
  20. [20]
    R. Fischer,Time Contraction and Psychomotor Performance Produced by Psilocybin, Nature (London)209, 433–434 (1966).Google Scholar
  21. [21]
    H.-J. Haase,Das therapeutische Achsensyndrom neuroleptischer Medikamente und seine Beziehungen zu extrapyramidaler Symptomatik, Fortschr.Neurol.-Psychiat.29, 245–268 (1961).PubMedGoogle Scholar
  22. [22]
    H. Denber, P. Rajotte andC. Wiart,Peinture et Effets Secondaires des Neuroleptiques Majeurs, Ann. Méd.-Psych.120, 11–30 (1962).Google Scholar
  23. [23]
    R. Fischer, On Creative, Psychotic and Ecstatic States, in: I. Jakob, ed.,Art Interpretation and Art Therapy, Psychiatry and Art, 2, pp. 33–65, Proc. 5th Intl. Colloquium of the Soc. Psychopathol. of Expression, Los Angeles, Calif., 1968 (S. Karger, Basel & New York 1969).Google Scholar
  24. [24]
    H. Rennert,Eigengesetze des bildnerischen Ausdrucks bei Schizophrenie, Psychiat., Neurol. Med. Psychol.15, 282–288 (1963).Google Scholar
  25. [25]
    H. Rennert,Die Merkmale schizophrener Bildnerei (Veb Gustav Fischer, Jena 1966).Google Scholar
  26. [26]
    H. Rennert,Die prognotische Bedeutung der ≪Horizontverschiebung≫ in der schizophrenen Bildnerei, Confin. Psychiat.12, 23–27 (1969).PubMedGoogle Scholar
  27. [27]
    H. Rennert,Die ≪vertikale Blickwinkelverschiebung≫ in der schizophrenen Bildnerei, Psychiat. Neurol. und Med. Psychol.21, 325–329 (1969).Google Scholar
  28. [28]
    S. Wapner andD. Krus,Behavioral Effects of LSD-25, Arch. Gen. Psychiat.1, 87–89 (1959).Google Scholar
  29. [29]
    D. Krus, O. Resnick andM. Raskin,Apparent Eye-Level Test, Arch. Gen. Psychiat.14, 419–427 (1966).PubMedGoogle Scholar
  30. [30]
    W. Wittreich andK. Radcliffe,The Influence of Simulated Mutilation Upon the Perception of the Human Figure, J. Abnormal Psychol.51, 493–495 (1955).Google Scholar
  31. [31]
    W. Wittreich,The Honi Phenomenon: A Case of Selective Perceptual Distortion, in: F. Kilpatrick, ed., Explorations in Transactional Psychology, 188–221, N. Y. Univ., New York 1961.Google Scholar
  32. [32]
    R. Fischer,Out on a (Phantom) Limb. Variations on the Theme: Stability of Body Image and the Golden Section, Persp. Biol. Med.12, 259–273 (1969).Google Scholar
  33. [33]
    M. Simmel,Phantom Experiences Following Amputation in Childhood, J. Neurol. Neurosurg. and Psychiat.25, 69–78 (1962).Google Scholar
  34. [34]
    L. Bender,Children's Reactions to Psychotomimetric Drugs, in: D. Efron, ed., Psychotomimetic Drugs, 265–271, Raven, New York 1969, p. 267.Google Scholar
  35. [35]
    R. Fischer,The Perception-Hallucination Continuum (A Re-Examination), Dis. Nerv. Syst.30, 161–171 (1969).PubMedGoogle Scholar
  36. [36]
    G. Sholem,On the Kabbalah and its Symbolism,R. Manheim, transl., Routledge and Kegan Paul, London 1965.Google Scholar
  37. [37]
    R. Bucke,Cosmic Consciousness, E. P. Dutton, New York 1926.Google Scholar
  38. [38]
    T. Spoerri, ed.,Beiträge zur Ekstase, Karger, Basel and New York 1968.Google Scholar
  39. [39]
    Saint Teresa,The Life of Saint Teresa of Avila by Herself, J. Cohen, transl., Clark, Edinburgh 1957.Google Scholar

Copyright information

© Birkhäuser-Verlag 1970

Authors and Affiliations

  • Roland Fischer
    • 1
  • Richard Hill
    • 1
  • Karen Thatcher
    • 1
  • James Scheib
    • 1
  1. 1.Division of Behavioral and Neurobiological Sciences, Department of Psychiatry and Pharmacology, College of MedicineThe Ohio State UniversityColumbusUSA

Personalised recommendations